Mirjam Fechter

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations

Bronwen E. Shaw, L.M. Ball, Meral Beksaç et al. · Bone Marrow Transplantation · 2010 · 61 citations

Medicine, Health Policy, Bioethics +14

Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues

Nina Worel, Andreas Buser, Hildegard Greinix et al. · Biology of Blood and Marrow Transplantation · 2015 · 57 citations · Full text

Medicine, Hematology, Stem Cell Transplantation +16

Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee

Robert Lown, Jennifer Philippe, Willis H. Navarro et al. · Bone Marrow Transplantation · 2014 · 53 citations

Medicine, Hematology, Stem Cell Biology +13